BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024GlobeNewsWire • 05/21/24
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced TermGlobeNewsWire • 05/21/24
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024GlobeNewsWire • 05/17/24
BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A HitInvestors Business Daily • 05/06/24
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024GlobeNewsWire • 04/22/24
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic CancerGlobeNewsWire • 04/07/24
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss ForecastsInvestors Business Daily • 03/20/24
BioNTech's stock sinks after earnings fall below expectations, hurt by writedowns of vaccine inventoryMarket Watch • 03/20/24
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateGlobeNewsWire • 03/20/24